These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The de novo design of an antibody combining site. Crystallographic analysis of the VL domain confirms the structural model. Essen LO; Skerra A J Mol Biol; 1994 Apr; 238(2):226-44. PubMed ID: 8158652 [TBL] [Abstract][Full Text] [Related]
3. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling. Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody. Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393 [TBL] [Abstract][Full Text] [Related]
5. A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. Dall'Acqua W; Goldman ER; Lin W; Teng C; Tsuchiya D; Li H; Ysern X; Braden BC; Li Y; Smith-Gill SJ; Mariuzza RA Biochemistry; 1998 Jun; 37(22):7981-91. PubMed ID: 9609690 [TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the complex of the variable domain of antibody D1.3 and turkey egg white lysozyme: a novel conformational change in antibody CDR-L3 selects for antigen. Braden BC; Fields BA; Ysern X; Goldbaum FA; Dall'Acqua W; Schwarz FP; Poljak RJ; Mariuzza RA J Mol Biol; 1996 Apr; 257(5):889-94. PubMed ID: 8632472 [TBL] [Abstract][Full Text] [Related]
7. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains. Honegger A; Malebranche AD; Röthlisberger D; Plückthun A Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of an Fv-Fv idiotope-anti-idiotope complex at 1.9 A resolution. Braden BC; Fields BA; Ysern X; Dall'Acqua W; Goldbaum FA; Poljak RJ; Mariuzza RA J Mol Biol; 1996 Nov; 264(1):137-51. PubMed ID: 8950273 [TBL] [Abstract][Full Text] [Related]
10. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues. Wu H; Nie Y; Huse WD; Watkins JD J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035 [TBL] [Abstract][Full Text] [Related]
11. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting. Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757 [TBL] [Abstract][Full Text] [Related]
12. Affinity maturation increases the stability and plasticity of the Fv domain of anti-protein antibodies. Acierno JP; Braden BC; Klinke S; Goldbaum FA; Cauerhff A J Mol Biol; 2007 Nov; 374(1):130-46. PubMed ID: 17916365 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: conformational influence of an engineered disulfide bond. Almog O; Benhar I; Vasmatzis G; Tordova M; Lee B; Pastan I; Gilliland GL Proteins; 1998 May; 31(2):128-38. PubMed ID: 9593187 [TBL] [Abstract][Full Text] [Related]
14. The rational construction of an antibody against cystatin: lessons from the crystal structure of an artificial Fab fragment. Schiweck W; Skerra A J Mol Biol; 1997 May; 268(5):934-51. PubMed ID: 9180382 [TBL] [Abstract][Full Text] [Related]
15. The pH-dependent structural variation of complementarity-determining region H3 in the crystal structures of the Fv fragment from an anti-dansyl monoclonal antibody. Nakasako M; Takahashi H; Shimba N; Shimada I; Arata Y J Mol Biol; 1999 Aug; 291(1):117-34. PubMed ID: 10438610 [TBL] [Abstract][Full Text] [Related]
16. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains. Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090 [TBL] [Abstract][Full Text] [Related]
17. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies. Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357 [TBL] [Abstract][Full Text] [Related]
19. Use of human germline genes in a CDR homology-based approach to antibody humanization. Hwang WY; Almagro JC; Buss TN; Tan P; Foote J Methods; 2005 May; 36(1):35-42. PubMed ID: 15848073 [TBL] [Abstract][Full Text] [Related]
20. Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding. Bhat TN; Bentley GA; Fischmann TO; Boulot G; Poljak RJ Nature; 1990 Oct; 347(6292):483-5. PubMed ID: 2215663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]